The C16orf74 high-expression group (with > 10% positive cancer cells in the tissue section) had significantly worse prognosis than the C16orf74 low-expression group (with ≤ 10% or no positive cancer cells in the tissue section) (median survival 10.1 months in the high-expression group vs. 20.7 months in the low-expression group, p = 0.028). Here, CLMB is linked to cancer.